SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032076
Filing Date
2022-11-14
Accepted
2022-11-14 16:23:16
Documents
92
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1395702
2 ex10-1.htm EX-10.1 55427
3 ex10-2.htm EX-10.2 62781
4 ex10-3.htm EX-10.3 33437
5 ex31-1.htm EX-31.1 19868
6 ex31-2.htm EX-31.2 19887
7 ex32-1.htm EX-32.1 9768
  Complete submission text file 0001493152-22-032076.txt   7906109

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE hrow-20220930.xsd EX-101.SCH 62690
9 XBRL CALCULATION FILE hrow-20220930_cal.xml EX-101.CAL 87518
10 XBRL DEFINITION FILE hrow-20220930_def.xml EX-101.DEF 315049
11 XBRL LABEL FILE hrow-20220930_lab.xml EX-101.LAB 505266
12 XBRL PRESENTATION FILE hrow-20220930_pre.xml EX-101.PRE 409534
86 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1298560
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 221386001
SIC: 2834 Pharmaceutical Preparations